Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“ Valneva ” or the “ Company ”), a specialty vaccine company, today announces that it has filed a prospectus supplement as part of the renewal of its ...
Finanznachrichten5d
Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program
Saint-Herblain (France), March 26, 2025 - Valneva SE (Nasdaq ... provide an update after each capital increase on a dedicated location on its corporate website in order to inform investors ...
Morningstar6d
Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program
Saint-Herblain (France), March 26, 2025 – Valneva SE (Nasdaq ... provide an update after each capital increase on a dedicated location on its corporate website in order to inform investors ...
TMCnet21m
Valneva's Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
With this extension, IXCHIQ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU).
Valneva to provide 40,000 IXCHIQ doses in France starting early April
SE announced earlier that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La ...
Yahoo Finance6d
Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program
Saint-Herblain (France), March 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“Valneva” or the “Company”), a specialty vaccine company, today announces that it has filed a ...
Pharmabiz5d
Valneva responds to French govt’s call for supply of chikungunya vaccine, Ixchiq
Valneva SE, a specialty vaccine company, announced that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La Réunion with its vaccine Ixchiq. In agreement ...
Yahoo Finance6d
Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program
Saint-Herblain (France), March 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“Valneva” or the “Company”), a specialty vaccine company, today announces that it has filed a prospectus ...
Yahoo Finance4d
Valneva SE (VALN)
Saint-Herblain (France), March 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“Valneva” or the “Company”), a specialty vaccine company, today announces that it has filed a ...
ETF Daily News5d
Valneva (NASDAQ:VALN) Shares Gap Down on Analyst Downgrade
Valneva had a negative net margin of 4.35% and a negative return on equity of 3.93%. The firm had revenue of $56.48 million during the quarter, compared to the consensus estimate of $55.64 million.
ETF Daily News6d
Guggenheim Has Lowered Expectations for Valneva (NASDAQ:VALN) Stock Price
Valneva (NASDAQ:VALN – Get Free Report) had its target price dropped by research analysts at Guggenheim from $17.00 to $15.00 in a research note issued to investors on Monday,Benzinga reports.